trans-4-(Carbobenzoxyamino)cyclohexanecarboxylic Acid>96.0%(HPLC)(T)25g

Octyl 4-O-a-D-glucopyranosyl-b-D-glucopyranoside, 95+%, 100mg

N,N-dibenzyl-1-phenylmethanesulfonamide, 97.0%, 10g

Oleic Acid>99.0%(GC)(T)5mL

7-BROMO-1,2,3,4-TETRAHYDRO-6-METHYLPYRIDO[2,3-B]PYRAZINE, 95.0%, 1g

tert-butyl (2S)-2-(4-phenyl-1H-imidazol-2-yl)pyrrolidine-1-carboxylate, 1g

ethyl 4-(4-cyanophenyl)-2-hydroxy-4-oxobut-2-enoate, 97%, 2.5g

7,8-Dimethoxy-3-(3-iodopropyl)-1,3-dihydro-2H-3-benzazepin-2-one, 95.0%, 1g

Methyl 4-((tert-butoxycarbonyl)(2-morpholino-2-oxoethyl)amino)benzoate, 5g

Quinoxalin-2-amine, 95.0%, 250mg

(2S,4R)-1-((S)-23-Azido-2-(tert-butyl)-4-oxo-6,9,12,15,18,21-hexaoxa-3-azatricosanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide, 98%, 100mg

IMAZODAN, 95.0%, 1g

3-METHYLTETRAHYDROFURAN-3-CARBOXYLIC ACID, 95.0%, 100mg